Bruce A. Leicher
2017 - Momenta Pharmaceuticals
Compensation breakdown
Non-Equity Incentive Plan | $144,200 |
---|---|
Option Awards | $498,762 |
Salary | $450,626 |
Stock Awards | $405,746 |
Other | $13,331 |
Total | $1,512,665 |
Leicher received $498.8K in option awards, accounting for 33% of the total pay in 2017.
Leicher also received $144.2K in non-equity incentive plan, $450.6K in salary, $405.7K in stock awards and $13.3K in other compensation.
Rankings
In 2017, Bruce A. Leicher's compensation ranked 6,947th out of 14,666 executives tracked by ExecPay. In other words, Leicher earned more than 52.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,947 | 53rd |
Manufacturing | 2,573 | 55th |
Chemicals And Allied Products | 832 | 60th |
Drugs | 646 | 63rd |
Biological Products, Except Diagnostic Substances | 119 | 62nd |
Leicher's colleagues
We found five more compensation records of executives who worked with Bruce A. Leicher at Momenta Pharmaceuticals in 2017.
2017
Craig Wheeler
Momenta Pharmaceuticals
Chief Executive Officer
2017
Santiago Arroyo
Momenta Pharmaceuticals
Chief Medical Officer
2017
Matthew Ottmer
Momenta Pharmaceuticals
Chief Operating Officer
2017
Ganesh Kaundinya
Momenta Pharmaceuticals
Chief Operating Officer
2017
Scott Storer
Momenta Pharmaceuticals